Form 8-K - Current report:
SEC Accession No. 0001558370-24-011808
Filing Date
2024-08-12
Accepted
2024-08-12 08:40:34
Documents
52
Period of Report
2024-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apre-20240812x8k.htm   iXBRL 8-K 41232
2 EX-99.1 apre-20240812xex99d1.htm EX-99.1 148809
3 EX-99.2 apre-20240812xex99d2.htm EX-99.2 57100
4 GRAPHIC apre-20240812xex99d2g001.jpg GRAPHIC 104201
5 GRAPHIC apre-20240812xex99d2g002.jpg GRAPHIC 336316
6 GRAPHIC apre-20240812xex99d2g003.jpg GRAPHIC 187813
7 GRAPHIC apre-20240812xex99d2g004.jpg GRAPHIC 121441
8 GRAPHIC apre-20240812xex99d2g005.jpg GRAPHIC 141068
9 GRAPHIC apre-20240812xex99d2g006.jpg GRAPHIC 186934
10 GRAPHIC apre-20240812xex99d2g007.jpg GRAPHIC 67544
11 GRAPHIC apre-20240812xex99d2g008.jpg GRAPHIC 141905
12 GRAPHIC apre-20240812xex99d2g009.jpg GRAPHIC 186786
13 GRAPHIC apre-20240812xex99d2g010.jpg GRAPHIC 138551
14 GRAPHIC apre-20240812xex99d2g011.jpg GRAPHIC 182027
15 GRAPHIC apre-20240812xex99d2g012.jpg GRAPHIC 62918
16 GRAPHIC apre-20240812xex99d2g013.jpg GRAPHIC 178810
17 GRAPHIC apre-20240812xex99d2g014.jpg GRAPHIC 120071
18 GRAPHIC apre-20240812xex99d2g015.jpg GRAPHIC 168943
19 GRAPHIC apre-20240812xex99d2g016.jpg GRAPHIC 140586
20 GRAPHIC apre-20240812xex99d2g017.jpg GRAPHIC 111281
21 GRAPHIC apre-20240812xex99d2g018.jpg GRAPHIC 139659
22 GRAPHIC apre-20240812xex99d2g019.jpg GRAPHIC 66695
23 GRAPHIC apre-20240812xex99d2g020.jpg GRAPHIC 232342
24 GRAPHIC apre-20240812xex99d2g021.jpg GRAPHIC 167531
25 GRAPHIC apre-20240812xex99d2g022.jpg GRAPHIC 162234
26 GRAPHIC apre-20240812xex99d2g023.jpg GRAPHIC 165853
27 GRAPHIC apre-20240812xex99d2g024.jpg GRAPHIC 138884
28 GRAPHIC apre-20240812xex99d2g025.jpg GRAPHIC 145484
29 GRAPHIC apre-20240812xex99d2g026.jpg GRAPHIC 90101
30 GRAPHIC apre-20240812xex99d2g027.jpg GRAPHIC 122299
31 GRAPHIC apre-20240812xex99d2g028.jpg GRAPHIC 65902
32 GRAPHIC apre-20240812xex99d2g029.jpg GRAPHIC 171275
33 GRAPHIC apre-20240812xex99d2g030.jpg GRAPHIC 105726
34 GRAPHIC apre-20240812xex99d2g031.jpg GRAPHIC 148778
35 GRAPHIC apre-20240812xex99d2g032.jpg GRAPHIC 88114
36 GRAPHIC apre-20240812xex99d2g033.jpg GRAPHIC 163016
37 GRAPHIC apre-20240812xex99d2g034.jpg GRAPHIC 150624
38 GRAPHIC apre-20240812xex99d2g035.jpg GRAPHIC 160733
  Complete submission text file 0001558370-24-011808.txt   7410805

Data Files

Seq Description Document Type Size
39 EX-101.SCH apre-20240812.xsd EX-101.SCH 4364
40 EX-101.DEF apre-20240812_def.xml EX-101.DEF 2842
41 EX-101.LAB apre-20240812_lab.xml EX-101.LAB 12243
42 EX-101.PRE apre-20240812_pre.xml EX-101.PRE 11769
54 EXTRACTED XBRL INSTANCE DOCUMENT apre-20240812x8k_htm.xml XML 4859
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 617-463-9385
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 241195028
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)